Shorter (GT)_n repeats in the haem-oxygenase 1 gene promoter are associated with better mid-term survival in subjects with coronary artery disease and abnormal ejection fraction

References

• Bai, C.H., et al., 2010. Shorter GT repeat polymorphism in the heme oxygenase-1 gene promoter has protective effect on ischemic stroke in dyslipidemia patients. Journal of biomedical science, 17 (1), 12.
   PubMedGoogle Scholar
• Chen, Y.H., et al., 2002. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Human genetics, 111 (1), 1–8.
   PubMed Web of Science ®Google Scholar
• Daenen, K.E., et al., 2016. Association of HO-1 (GT)n promoter polymorphism and cardiovascular disease: a reanalysis of the literature. Canadian journal of cardiology, 32 (2), 160–168.
   PubMed Web of Science ®Google Scholar
• Exner, M., et al., 2001. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. Journal of endovascular therapy, 8 (5), 433–440.
   PubMed Web of Science ®Google Scholar
• Furchgott, R.F., et al., 1991. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood vessels, 28 (1–3), 52–61.
   PubMedGoogle Scholar
• Idriss, N.K., et al., 2008. Hemoxygenase-1 in cardiovascular disease. Journal of the American college of cardiology, 52 (12), 971–978.
   PubMed Web of Science ®Google Scholar
• Kaneda, H., et al., 2002. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arteriosclerosis, thrombosis, and vascular biology, 22 (10), 1680–1685.
   PubMed Web of Science ®Google Scholar
• Kusmic, C., et al., 2014. Up-regulation of heme oxygenase-1 after infarct initiation reduces mortality, infarct size and left ventricular remodeling: experimental evidence and proof of concept. Journal of translational medicine, 12, 89.
   PubMed Web of Science ®Google Scholar
• Liang, K.W., et al., 2013. Shorter GT repeats in the heme oxygenase-1 gene promoter are associated with a lower severity score in coronary artery disease. Journal of the Chinese medical association, 76 (6), 312–318.
   PubMed Web of Science ®Google Scholar
• Liang, K.W., et al., 2021. Subjects with coronary artery disease and reduced ejection fraction have longer (GT)n repeats in the heme-oxygenase 1 gene promoter. Heart and vessels, 36 (5), 615–620.
   PubMed Web of Science ®Google Scholar
• Lin, C.C., et al., 2008. Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1. Arteriosclerosis, thrombosis, and vascular biology, 28 (4), 739–745.
   PubMed Web of Science ®Google Scholar
• Ndisang, J.F., et al., 2014. Heme oxygenase suppresses markers of heart failure and ameliorates cardiomyopathy in L-NAME-induced hypertension. European journal of pharmacology, 734, 23–34.
   PubMed Web of Science ®Google Scholar
• Pechlaner, R., et al., 2015. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with progressive atherosclerosis and incident cardiovascular disease. Arteriosclerosis, thrombosis, and vascular biology, 35 (1), 229–236.
   PubMed Web of Science ®Google Scholar
• Ponikowski, P., et al., 2016. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur heart J, 37, 2129–2200.
   PubMed Web of Science ®Google Scholar
• Qiao, H., et al., 2014. Association between heme oxygenase 1 gene promoter polymorphisms and susceptibility to coronary artery disease: a HuGE review and meta-analysis. American journal of epidemiology, 179 (9), 1039–1048.
   PubMed Web of Science ®Google Scholar
• Sianos, G., et al., 2005. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention, 1 (2), 219–227.
   PubMedGoogle Scholar
• Taha, H., et al., 2010. Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants. Arteriosclerosis, thrombosis, and vascular biology, 30 (8), 1634–1641.
   PubMed Web of Science ®Google Scholar
• Wang, G., et al., 2010. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation, 121 (17), 1912–1925.
   PubMed Web of Science ®Google Scholar
• Wenzel, P., et al., 2015. Heme oxygenase-1 suppresses a pro-inflammatory phenotype in monocytes and determines endothelial function and arterial hypertension in mice and humans. European heart journal, 36 (48), 3437–3446.
   PubMed Web of Science ®Google Scholar
• Wu, M.L., et al., 2011. A central role of heme oxygenase-1 in cardiovascular protection. Antioxidants & redox signaling, 15 (7), 1835–1846.
   PubMed Web of Science ®Google Scholar
• Wu, M.L., et al., 2011. Heme oxygenase-1 in inflammation and cardiovascular disease. American journal of cardiovascular disease, 1 (2), 150–158.
   PubMedGoogle Scholar
• Wu, M.M., et al., 2010. GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan. Toxicology and applied pharmacology, 248 (3), 226–233.
   PubMed Web of Science ®Google Scholar
• Yancy, C.W., et al., 2017. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. Circulation, 136, e137–e161.
   PubMed Web of Science ®Google Scholar
• Yet, S.F., et al., 2001. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circulation research, 89 (2), 168–173.
   PubMed Web of Science ®Google Scholar
• Zhang, M.M., et al., 2016. Heme oxygenase-1 gene promoter polymorphisms are associated with coronary heart disease and restenosis after percutaneous coronary intervention: a meta-analysis. Oncotarget, 7 (50), 83437–83450.
   PubMedGoogle Scholar